EYLEA is an FDA-approved, anti-VEGF, administered intravitreal injection to treat WET AMD, DME, MefRVO, and DR. Look here for more information about EYLEA. See Safety Information and full Prescribing Information.

EYLEA has several programs available depending on your insurance situation to help eligible patients with the cost of EYLEA and any EYLEA patient assistance.

Learn how EYLEA works to treat eye diseases like Wet AMD, DR, & MEfRVO and has helped treat millions of people. Learn more about EYLEA here. See Safety Information and full Prescribing Information.

Learn the recommended dosing for EYLEA for Wet AMD, DR, DME, and MEfRVO. Review full EYLEA administration and dosing information here. See Safety Information and full Prescribing Information.

Learn the symptoms of different eye diseases like Wet AMD, DME, DR, and MEfRVO. Learn more about these Retinal Disease Conditions with EYLEA here. See Safety Information and full Prescribing Information.

Utilize the time with your eye care team with EYLEA's appointment preparation tips. Get useful tips for after eye injection care once you finished treatment. For Wet AMD, DME, DR, or MEfRVO. See Safety Information and full Prescribing Information.

Find answers to commonly asked questions about EYLEA injections for Wet AMD, DME, DR, or MEfRVO. Learn about the diabetic eye diseases and their treatment here. See Safety Information and full Prescribing Information.

EYLEA® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR). Please click here for the full Prescribing Information for EYLEA HD and

Hear what real people have to say about their experience with EYLEA. Learn how patients have treated their retinal eye disease with EYLEA. For Wet AMD, DME, DR, or MEfRVO. See Safety Information and full Prescribing Information.

Retinopathy of Prematurity can impact your baby's eyes and vision. Discover EYLEA, the first and only FDA-approved anti-VEGF treatment for retinopathy of prematurity.